About 70% of cases positive for estrogen receptors (ERs) expression, and patients with ER-positive BC generally receive anti-hormonal therapy, mainly based on anti-estrogens, selective ER modulators (SERMs), or inhibitors of aromatase, which sinthesizes estrogens. The gene discussed is ESR1; the disease is breast cancer.